Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ) has provided an announcement.
NeuroScientific Biopharmaceuticals Ltd has announced the formation of a Clinical & Scientific Advisory Board to guide its scientific innovation and product development. The board, led by Chief Medical Officer Dr. Catherine Cole, includes experts in nephrology, gastroenterology, and respiratory medicine. This strategic move aims to enhance the company’s clinical strategy and address unmet medical needs in immune-mediated inflammatory disorders.
More about Neuroscientific Biopharmaceuticals Ltd.
NeuroScientific Biopharmaceuticals Ltd is an Australian biotechnology company focused on developing novel technologies for immune-mediated inflammatory diseases.
Average Trading Volume: 348,444
Technical Sentiment Signal: Buy
Current Market Cap: A$46.56M
See more insights into NSB stock on TipRanks’ Stock Analysis page.